L-703717

N/A

Report date: 2022/08/24 20:00:31

NME

Base Information

Drug NameL-703717

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlutamate receptors inhibitors

TargetsGlutamate receptors

Therapy Area/IndicationsEpilepsyStroke

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMerck & Co

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMerck & Co

Active IndicationsN/A

Inactive IndicationsEpilepsyStroke

ATC CodeN/A